# Response to “A case of 5-FU related severe toxicity associated to the p.Y186C DPYD variant”

## Metadata
**Authors:** Steven M Offer, Robert B Diasio
**Journal:** Clinical pharmacology and therapeutics
**Date:** 2013 Oct 9
**DOI:** [10.1038/clpt.2013.207](https://doi.org/10.1038/clpt.2013.207)
**PMID:** 24107927
**PMCID:** PMC4112558
**URL:** https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112558/
**PDF:** [https://pmc.ncbi.nlm.nih.gov/articles/PMC4112558/pdf/nihms597207.pdf](https://pmc.ncbi.nlm.nih.gov/articles/PMC4112558/pdf/nihms597207.pdf)

## Footnotes

## References

1. Zaanan A, Dumont LM, Loriot MA, Taieb J, Narjoz C. A case of 5-FU related severe toxicity associated to the p.Y186C DPYD variant. Clin Pharmacol Ther. 2013 doi: 10.1038/clpt.2013.183.  [DOI](https://doi.org/10.1038/clpt.2013.183) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/24037119/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=A%20case%20of%205-FU%20related%20severe%20toxicity%20associated%20to%20the%20p.Y186C%20DPYD%20variant&author=A%20Zaanan&author=LM%20Dumont&author=MA%20Loriot&author=J%20Taieb&author=C%20Narjoz&publication_year=2013&pmid=24037119&doi=10.1038/clpt.2013.183&)

2. Saif MW, Lee AM, Offer SM, McConnell K, Relias V, Diasio RB. A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxicity potential for an individualized medicine approach. Mayo Clin Proc. 2013 doi: 10.1016/j.mayocp.2013.09.008. Manuscript in Press.  [DOI](https://doi.org/10.1016/j.mayocp.2013.09.008) | [PMC free article](/articles/PMC4071869/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/24388031/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Mayo%20Clin%20Proc&title=A%20DPYD%20variant%20(Y186C)%20specific%20to%20individuals%20of%20African%20descent%20in%20a%20patient%20with%20life-threatening%205-FU%20toxicity%20potential%20for%20an%20individualized%20medicine%20approach&author=MW%20Saif&author=AM%20Lee&author=SM%20Offer&author=K%20McConnell&author=V%20Relias&publication_year=2013&pmid=24388031&doi=10.1016/j.mayocp.2013.09.008&)

3. Offer SM, Lee AM, Mattison LK, Fossum C, Wegner NJ, Diasio RB. A DPYD Variant (Y186C) in Individuals of African Ancestry Is Associated With Reduced DPD Enzyme Activity. Clin Pharmacol Ther. 2013;94(1):158–166. doi: 10.1038/clpt.2013.69.  [DOI](https://doi.org/10.1038/clpt.2013.69) | [PMC free article](/articles/PMC3821392/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23588312/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=A%20DPYD%20Variant%20(Y186C)%20in%20Individuals%20of%20African%20Ancestry%20Is%20Associated%20With%20Reduced%20DPD%20Enzyme%20Activity&author=SM%20Offer&author=AM%20Lee&author=LK%20Mattison&author=C%20Fossum&author=NJ%20Wegner&volume=94&issue=1&publication_year=2013&pages=158-166&pmid=23588312&doi=10.1038/clpt.2013.69&)

4. Offer SM, Wegner NJ, Fossum C, Wang K, Diasio RB. Phenotypic profiling of DPYD variations relevant to 5-fluorouracil sensitivity using real-time cellular analysis and in vitro measurement of enzyme activity. Cancer Res. 2013;73(6):1958–1968. doi: 10.1158/0008-5472.CAN-12-3858.  [DOI](https://doi.org/10.1158/0008-5472.CAN-12-3858) | [PMC free article](/articles/PMC3602211/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23328581/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&title=Phenotypic%20profiling%20of%20DPYD%20variations%20relevant%20to%205-fluorouracil%20sensitivity%20using%20real-time%20cellular%20analysis%20and%20in%20vitro%20measurement%20of%20enzyme%20activity&author=SM%20Offer&author=NJ%20Wegner&author=C%20Fossum&author=K%20Wang&author=RB%20Diasio&volume=73&issue=6&publication_year=2013&pages=1958-1968&pmid=23328581&doi=10.1158/0008-5472.CAN-12-3858&)

5. Caudle KE, Thorn CF, Klein TE, Swen JJ, McLeod HL, Diasio RB, et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for Dihydropyrimidine Dehydrogenase Genotype and Fluoropyrimidine Dosing. Clin Pharmacol Ther. 2013 doi: 10.1038/clpt.2013.172.  [DOI](https://doi.org/10.1038/clpt.2013.172) | [PMC free article](/articles/PMC3831181/) | [PubMed](https://pubmed.ncbi.nlm.nih.gov/23988873/) | [Google Scholar](https://scholar.google.com/scholar_lookup?journal=Clin%20Pharmacol%20Ther&title=Clinical%20Pharmacogenetics%20Implementation%20Consortium%20Guidelines%20for%20Dihydropyrimidine%20Dehydrogenase%20Genotype%20and%20Fluoropyrimidine%20Dosing&author=KE%20Caudle&author=CF%20Thorn&author=TE%20Klein&author=JJ%20Swen&author=HL%20McLeod&publication_year=2013&pmid=23988873&doi=10.1038/clpt.2013.172&)
